Review



nih 3t3 cell line  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Santa Cruz Biotechnology nih 3t3 cell line
    Nih 3t3 Cell Line, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nih+3t3+cell+nuclear+extract/NIH%2F3T3+nuclear+extract/pm27664839-76-7-16
    Average 93 stars, based on 12 article reviews
    nih 3t3 cell line - by Bioz Stars, 2026-08
    93/100 stars

    Images



    Similar Products

    93
    Santa Cruz Biotechnology nih 3t3 cell line
    Nih 3t3 Cell Line, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nih+3t3+cell+nuclear+extract/NIH%2F3T3+nuclear+extract/pm27664839-76-7-16
    Average 93 stars, based on 1 article reviews
    nih 3t3 cell line - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    85
    Santa Cruz Biotechnology health nih 3t3 phorbol whole cell lysate
    Health Nih 3t3 Phorbol Whole Cell Lysate, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nih+3t3+cell+nuclear+extract/NIH%2F3T3+%2B+PMA+nuclear+extract/pm17224790-61-25-38
    Average 85 stars, based on 1 article reviews
    health nih 3t3 phorbol whole cell lysate - by Bioz Stars, 2026-08
    85/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology nih 3t3 cells
    Nih 3t3 Cells, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nih+3t3+cell+nuclear+extract/NIH%2F3T3+nuclear+extract/pm17027328-112-11-14
    Average 93 stars, based on 1 article reviews
    nih 3t3 cells - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    85
    Santa Cruz Biotechnology nih 3t3 cell nuclear extract
    FIG. 1. Size fractionation of SRE BP DNA binding activity. (A) Nuclear extract (nuc ex) from <t>NIH</t> <t>3T3</t> cells was fractionated on an SDS–10% polyacryl- amide minigel and transferred to an Immobilon-P membrane, and the separated proteins were renatured in an elution solution as described in Materials and Methods. Gel shift assays were performed with 10 ml of each size fraction and 0.5 ng of 32P-labeled SRE DNA in the presence of 100 ng of poly(dI-dC):poly(dI- dC), as described in Materials and Methods. A scale of apparent molecular masses in kilodaltons, based on protein standards run in parallel on the SDS gel, is shown above lanes 1 to 16. In lane 17, approximately 5 mg of unfractionated nuclear extract from BALB/c 3T3 cells was mixed with 0.5 ng of 32P-labeled SRE DNA in the presence of 500 ng of poly(dI-dC):poly(dI-dC) as described in Materials and Methods. SRF and SRE BP complexes are indicated. (B) Gel shift assays were performed with 5 mg of unfractionated nuclear extract as in panel A, lane 17 (lane 1), 5 ml each of the 38- and 20-kDa SDS-sized fractions mixed at 378C for 20 min prior to DNA addition (lane 2), 5 ml of the 20-kDa SDS-sized fraction (lane 3), or 5 ml of the 38-kDa SDS-sized fraction (lane 4). Protein samples were mixed with 0.5 ng of 32P-labeled SRE DNA in the presence of 100 ng of poly(dI-dC):poly(dI-dC) as described in Materials and Methods except for lane 1, which contained 500 ng of poly(dI-dC):poly(dI-dC). Ten nanograms of aprotinin was added to the protein sample shown in lane 2 prior to incubation at 378C. This figure was prepared with a Mirror 800 color scanner and a Power Macintosh 8100/80 with Adobe Photoshop 2.5.1 and Adobe Illustrator 5.5.
    Nih 3t3 Cell Nuclear Extract, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nih+3t3+cell+nuclear+extract/NIH%2F3T3+%2B+PMA+nuclear+extract/10__1128_slash_mcb__17__3__1744-212-4-54
    Average 85 stars, based on 1 article reviews
    nih 3t3 cell nuclear extract - by Bioz Stars, 2026-08
    85/100 stars
      Buy from Supplier

    Image Search Results


    FIG. 1. Size fractionation of SRE BP DNA binding activity. (A) Nuclear extract (nuc ex) from NIH 3T3 cells was fractionated on an SDS–10% polyacryl- amide minigel and transferred to an Immobilon-P membrane, and the separated proteins were renatured in an elution solution as described in Materials and Methods. Gel shift assays were performed with 10 ml of each size fraction and 0.5 ng of 32P-labeled SRE DNA in the presence of 100 ng of poly(dI-dC):poly(dI- dC), as described in Materials and Methods. A scale of apparent molecular masses in kilodaltons, based on protein standards run in parallel on the SDS gel, is shown above lanes 1 to 16. In lane 17, approximately 5 mg of unfractionated nuclear extract from BALB/c 3T3 cells was mixed with 0.5 ng of 32P-labeled SRE DNA in the presence of 500 ng of poly(dI-dC):poly(dI-dC) as described in Materials and Methods. SRF and SRE BP complexes are indicated. (B) Gel shift assays were performed with 5 mg of unfractionated nuclear extract as in panel A, lane 17 (lane 1), 5 ml each of the 38- and 20-kDa SDS-sized fractions mixed at 378C for 20 min prior to DNA addition (lane 2), 5 ml of the 20-kDa SDS-sized fraction (lane 3), or 5 ml of the 38-kDa SDS-sized fraction (lane 4). Protein samples were mixed with 0.5 ng of 32P-labeled SRE DNA in the presence of 100 ng of poly(dI-dC):poly(dI-dC) as described in Materials and Methods except for lane 1, which contained 500 ng of poly(dI-dC):poly(dI-dC). Ten nanograms of aprotinin was added to the protein sample shown in lane 2 prior to incubation at 378C. This figure was prepared with a Mirror 800 color scanner and a Power Macintosh 8100/80 with Adobe Photoshop 2.5.1 and Adobe Illustrator 5.5.

    Journal: Molecular and Cellular Biology

    Article Title: Regulation of the cfos serum response element by C/EBPbeta

    doi: 10.1128/mcb.17.3.1744

    Figure Lengend Snippet: FIG. 1. Size fractionation of SRE BP DNA binding activity. (A) Nuclear extract (nuc ex) from NIH 3T3 cells was fractionated on an SDS–10% polyacryl- amide minigel and transferred to an Immobilon-P membrane, and the separated proteins were renatured in an elution solution as described in Materials and Methods. Gel shift assays were performed with 10 ml of each size fraction and 0.5 ng of 32P-labeled SRE DNA in the presence of 100 ng of poly(dI-dC):poly(dI- dC), as described in Materials and Methods. A scale of apparent molecular masses in kilodaltons, based on protein standards run in parallel on the SDS gel, is shown above lanes 1 to 16. In lane 17, approximately 5 mg of unfractionated nuclear extract from BALB/c 3T3 cells was mixed with 0.5 ng of 32P-labeled SRE DNA in the presence of 500 ng of poly(dI-dC):poly(dI-dC) as described in Materials and Methods. SRF and SRE BP complexes are indicated. (B) Gel shift assays were performed with 5 mg of unfractionated nuclear extract as in panel A, lane 17 (lane 1), 5 ml each of the 38- and 20-kDa SDS-sized fractions mixed at 378C for 20 min prior to DNA addition (lane 2), 5 ml of the 20-kDa SDS-sized fraction (lane 3), or 5 ml of the 38-kDa SDS-sized fraction (lane 4). Protein samples were mixed with 0.5 ng of 32P-labeled SRE DNA in the presence of 100 ng of poly(dI-dC):poly(dI-dC) as described in Materials and Methods except for lane 1, which contained 500 ng of poly(dI-dC):poly(dI-dC). Ten nanograms of aprotinin was added to the protein sample shown in lane 2 prior to incubation at 378C. This figure was prepared with a Mirror 800 color scanner and a Power Macintosh 8100/80 with Adobe Photoshop 2.5.1 and Adobe Illustrator 5.5.

    Article Snippet: Approximately 8 mg of NIH 3T3 cell nuclear extract was mixed with 1 mg of BSA (lane 1), 1 ml of guinea pig preimmune serum (lane 2), 1 ml of guinea pig affinity-purified anti-LAP antibody (lane 3), or 1 ml of C/EBPb (lane 4), C/EBPa (lane 5), or E12 (lane 6) peptide antibodies from Santa Cruz Biotechnology in the presence of 20 ng of aprotinin at 48C for 2 h. Protein samples were then mixed with 1 ng of 32P-labeled SRE DNA in the presence of 2 mg of poly(dI-dC):poly(dI-dC) as described in Materials and Methods for buffer I conditions.

    Techniques: Fractionation, Binding Assay, Activity Assay, Membrane, Gel Shift, Labeling, SDS-Gel, Incubation

    FIG. 2. p35C/EBPb and p20C/EBPb contribute to SRE BP DNA binding activity. (A) Nuclear extract from NIH 3T3 cells was fractionated on an SDS– 12% polyacrylamide gel and transferred to an Immobilon-P membrane. One lane was processed for Western blotting with anti-C/EBPb peptide antibody, while the separated proteins with apparent molecular masses between 66 and 14 kDa were renatured in elution solution from a parallel lane as described in Materials and Methods. Gel shift assays were performed with 10 ml of each size fraction and 0.5 ng of 32P-labeled SRE DNA in the presence of 500 ng of poly(dI-dC): poly(dI-dC) as described in Materials and Methods. A scale of apparent molec- ular masses in kilodaltons, based on protein standards run in parallel on the SDS gel and detected on the Immobilon-P filter by Ponceau S staining, is shown above the lanes. (B) Ten microliters of the SDS-sized fractions from the lanes indicated in panel A was preincubated for 10 min at 378C with 1 ml of the indicated peptide antibodies (Santa Cruz Biotechnology) or 1 ml of 1-mg/ml BSA in the presence of 20 ng of aprotinin. Protein samples were then mixed with 0.5 ng of 32P-labeled SRE DNA in the presence of 500 ng of poly(dI-dC):poly(dI-dC) as described in Materials and Methods. This figure was prepared with a Mirror 800 color scan- ner and a Power Macintosh 8100/80 with Adobe Photoshop 2.5.1 and Adobe Illustrator 5.5.

    Journal: Molecular and Cellular Biology

    Article Title: Regulation of the cfos serum response element by C/EBPbeta

    doi: 10.1128/mcb.17.3.1744

    Figure Lengend Snippet: FIG. 2. p35C/EBPb and p20C/EBPb contribute to SRE BP DNA binding activity. (A) Nuclear extract from NIH 3T3 cells was fractionated on an SDS– 12% polyacrylamide gel and transferred to an Immobilon-P membrane. One lane was processed for Western blotting with anti-C/EBPb peptide antibody, while the separated proteins with apparent molecular masses between 66 and 14 kDa were renatured in elution solution from a parallel lane as described in Materials and Methods. Gel shift assays were performed with 10 ml of each size fraction and 0.5 ng of 32P-labeled SRE DNA in the presence of 500 ng of poly(dI-dC): poly(dI-dC) as described in Materials and Methods. A scale of apparent molec- ular masses in kilodaltons, based on protein standards run in parallel on the SDS gel and detected on the Immobilon-P filter by Ponceau S staining, is shown above the lanes. (B) Ten microliters of the SDS-sized fractions from the lanes indicated in panel A was preincubated for 10 min at 378C with 1 ml of the indicated peptide antibodies (Santa Cruz Biotechnology) or 1 ml of 1-mg/ml BSA in the presence of 20 ng of aprotinin. Protein samples were then mixed with 0.5 ng of 32P-labeled SRE DNA in the presence of 500 ng of poly(dI-dC):poly(dI-dC) as described in Materials and Methods. This figure was prepared with a Mirror 800 color scan- ner and a Power Macintosh 8100/80 with Adobe Photoshop 2.5.1 and Adobe Illustrator 5.5.

    Article Snippet: Approximately 8 mg of NIH 3T3 cell nuclear extract was mixed with 1 mg of BSA (lane 1), 1 ml of guinea pig preimmune serum (lane 2), 1 ml of guinea pig affinity-purified anti-LAP antibody (lane 3), or 1 ml of C/EBPb (lane 4), C/EBPa (lane 5), or E12 (lane 6) peptide antibodies from Santa Cruz Biotechnology in the presence of 20 ng of aprotinin at 48C for 2 h. Protein samples were then mixed with 1 ng of 32P-labeled SRE DNA in the presence of 2 mg of poly(dI-dC):poly(dI-dC) as described in Materials and Methods for buffer I conditions.

    Techniques: Binding Assay, Activity Assay, Membrane, Western Blot, Gel Shift, Labeling, SDS-Gel, Staining

    FIG. 3. Effect of C/EBPb antibodies on SRE BP DNA binding activity in nuclear extract. Approximately 8 mg of NIH 3T3 cell nuclear extract was mixed with 1 mg of BSA (lane 1), 1 ml of guinea pig preimmune serum (lane 2), 1 ml of guinea pig affinity-purified anti-LAP antibody (lane 3), or 1 ml of C/EBPb (lane 4), C/EBPa (lane 5), or E12 (lane 6) peptide antibodies from Santa Cruz Biotechnology in the presence of 20 ng of aprotinin at 48C for 2 h. Protein samples were then mixed with 1 ng of 32P-labeled SRE DNA in the presence of 2 mg of poly(dI-dC):poly(dI-dC) as described in Materials and Methods for buffer I conditions. Specific SRF-DNA or C/EBPb protein-DNA complexes are indicated. The radioactivity levels in specific protein-DNA complexes on the dried gel were quantified with a Bio-Rad molecular imager. The graph represents the decrease in SRE BP complex formation with antibody or preimmune serum incubation. The amount of SRE BP complex formed when nuclear extract was incubated with BSA was assigned a value of 100%. Data are the averages of two separate experiments for the E12 antibody, three separate experiments for the guinea pig antibody and preimmune serum, and five separate experiments for the Santa Cruz Biotechnology C/EBP antibodies and BSA. The average error in the determinations was 14%. This figure was prepared with a Mirror 800 color scanner and a Power Macintosh 8100/80 with Adobe Photoshop 2.5.1 and Adobe Illustrator 5.5.

    Journal: Molecular and Cellular Biology

    Article Title: Regulation of the cfos serum response element by C/EBPbeta

    doi: 10.1128/mcb.17.3.1744

    Figure Lengend Snippet: FIG. 3. Effect of C/EBPb antibodies on SRE BP DNA binding activity in nuclear extract. Approximately 8 mg of NIH 3T3 cell nuclear extract was mixed with 1 mg of BSA (lane 1), 1 ml of guinea pig preimmune serum (lane 2), 1 ml of guinea pig affinity-purified anti-LAP antibody (lane 3), or 1 ml of C/EBPb (lane 4), C/EBPa (lane 5), or E12 (lane 6) peptide antibodies from Santa Cruz Biotechnology in the presence of 20 ng of aprotinin at 48C for 2 h. Protein samples were then mixed with 1 ng of 32P-labeled SRE DNA in the presence of 2 mg of poly(dI-dC):poly(dI-dC) as described in Materials and Methods for buffer I conditions. Specific SRF-DNA or C/EBPb protein-DNA complexes are indicated. The radioactivity levels in specific protein-DNA complexes on the dried gel were quantified with a Bio-Rad molecular imager. The graph represents the decrease in SRE BP complex formation with antibody or preimmune serum incubation. The amount of SRE BP complex formed when nuclear extract was incubated with BSA was assigned a value of 100%. Data are the averages of two separate experiments for the E12 antibody, three separate experiments for the guinea pig antibody and preimmune serum, and five separate experiments for the Santa Cruz Biotechnology C/EBP antibodies and BSA. The average error in the determinations was 14%. This figure was prepared with a Mirror 800 color scanner and a Power Macintosh 8100/80 with Adobe Photoshop 2.5.1 and Adobe Illustrator 5.5.

    Article Snippet: Approximately 8 mg of NIH 3T3 cell nuclear extract was mixed with 1 mg of BSA (lane 1), 1 ml of guinea pig preimmune serum (lane 2), 1 ml of guinea pig affinity-purified anti-LAP antibody (lane 3), or 1 ml of C/EBPb (lane 4), C/EBPa (lane 5), or E12 (lane 6) peptide antibodies from Santa Cruz Biotechnology in the presence of 20 ng of aprotinin at 48C for 2 h. Protein samples were then mixed with 1 ng of 32P-labeled SRE DNA in the presence of 2 mg of poly(dI-dC):poly(dI-dC) as described in Materials and Methods for buffer I conditions.

    Techniques: Binding Assay, Activity Assay, Labeling, Radioactivity, Incubation

    FIG. 4. Regulation of the cfos SRE by p20C/EBPb and p35C/EBPb. NIH 3T3 cells were transfected as described in Materials and Methods with 10 mg of cfos SRE CAT reporter gene and either 2.5 mg of CMV-4 vector (1CMV vector), 2.5 mg of CMV-LAP (p35) (1LAP), 0.5 mg of CMV-LIP(p20) (1LIP), or 1 mg of CMV-LAP and 0.5 mg of CMV-LIP (1LAP/LIP). Total DNA in each transfection was adjusted to 15 mg with pUC19 DNA. Twenty-four hours after transfection, cells were serum deprived for 36 h and all but the plates harvested at time zero were stimulated with 15% fetal calf serum as described in Materials and Methods. Cells were harvested at the indicated times, and CAT activity was measured as described in Materials and Methods. Fold induction was calculated as the increase in CAT activity relative to that obtained with the reporter gene plus pUC19 DNA in serum-deprived cells at time 0. Values are the averages of three independent experiments, and error bars show standard deviations.

    Journal: Molecular and Cellular Biology

    Article Title: Regulation of the cfos serum response element by C/EBPbeta

    doi: 10.1128/mcb.17.3.1744

    Figure Lengend Snippet: FIG. 4. Regulation of the cfos SRE by p20C/EBPb and p35C/EBPb. NIH 3T3 cells were transfected as described in Materials and Methods with 10 mg of cfos SRE CAT reporter gene and either 2.5 mg of CMV-4 vector (1CMV vector), 2.5 mg of CMV-LAP (p35) (1LAP), 0.5 mg of CMV-LIP(p20) (1LIP), or 1 mg of CMV-LAP and 0.5 mg of CMV-LIP (1LAP/LIP). Total DNA in each transfection was adjusted to 15 mg with pUC19 DNA. Twenty-four hours after transfection, cells were serum deprived for 36 h and all but the plates harvested at time zero were stimulated with 15% fetal calf serum as described in Materials and Methods. Cells were harvested at the indicated times, and CAT activity was measured as described in Materials and Methods. Fold induction was calculated as the increase in CAT activity relative to that obtained with the reporter gene plus pUC19 DNA in serum-deprived cells at time 0. Values are the averages of three independent experiments, and error bars show standard deviations.

    Article Snippet: Approximately 8 mg of NIH 3T3 cell nuclear extract was mixed with 1 mg of BSA (lane 1), 1 ml of guinea pig preimmune serum (lane 2), 1 ml of guinea pig affinity-purified anti-LAP antibody (lane 3), or 1 ml of C/EBPb (lane 4), C/EBPa (lane 5), or E12 (lane 6) peptide antibodies from Santa Cruz Biotechnology in the presence of 20 ng of aprotinin at 48C for 2 h. Protein samples were then mixed with 1 ng of 32P-labeled SRE DNA in the presence of 2 mg of poly(dI-dC):poly(dI-dC) as described in Materials and Methods for buffer I conditions.

    Techniques: Transfection, Plasmid Preparation, Activity Assay

    FIG. 5. Regulation of the cfos SRE by C/EBPb is independent of TCF binding. NIH 3T3 cells were transfected as described in Materials and Methods with 10 mg of a TCF mutant SRE CAT reporter gene (solid symbols) and either 2.5 mg of CMV-4 vector (circles), 2.5 mg of CMV-LAP (p35) (squares, solid lines), 0.5 mg of CMV-LIP(p20) (triangles), or 2.5 mg of CMV–NF-IL6 (squares, broken line). Parallel experiments with the wild-type SRE CAT reporter gene are denoted by open symbols. CAT activity is expressed as fold increase, calcu- lated as described in the legend to Fig. 4. Error bars have been omitted for clarity; however, the average error was 61.6-fold for the CMV-4 and CMV-LIP transfections, 611-fold for the CMV-LAP transfections, and 617-fold for the CMV–NF-IL6 transfections.

    Journal: Molecular and Cellular Biology

    Article Title: Regulation of the cfos serum response element by C/EBPbeta

    doi: 10.1128/mcb.17.3.1744

    Figure Lengend Snippet: FIG. 5. Regulation of the cfos SRE by C/EBPb is independent of TCF binding. NIH 3T3 cells were transfected as described in Materials and Methods with 10 mg of a TCF mutant SRE CAT reporter gene (solid symbols) and either 2.5 mg of CMV-4 vector (circles), 2.5 mg of CMV-LAP (p35) (squares, solid lines), 0.5 mg of CMV-LIP(p20) (triangles), or 2.5 mg of CMV–NF-IL6 (squares, broken line). Parallel experiments with the wild-type SRE CAT reporter gene are denoted by open symbols. CAT activity is expressed as fold increase, calcu- lated as described in the legend to Fig. 4. Error bars have been omitted for clarity; however, the average error was 61.6-fold for the CMV-4 and CMV-LIP transfections, 611-fold for the CMV-LAP transfections, and 617-fold for the CMV–NF-IL6 transfections.

    Article Snippet: Approximately 8 mg of NIH 3T3 cell nuclear extract was mixed with 1 mg of BSA (lane 1), 1 ml of guinea pig preimmune serum (lane 2), 1 ml of guinea pig affinity-purified anti-LAP antibody (lane 3), or 1 ml of C/EBPb (lane 4), C/EBPa (lane 5), or E12 (lane 6) peptide antibodies from Santa Cruz Biotechnology in the presence of 20 ng of aprotinin at 48C for 2 h. Protein samples were then mixed with 1 ng of 32P-labeled SRE DNA in the presence of 2 mg of poly(dI-dC):poly(dI-dC) as described in Materials and Methods for buffer I conditions.

    Techniques: Binding Assay, Transfection, Mutagenesis, Plasmid Preparation, Activity Assay

    FIG. 7. C/EBPb(lz2) inhibits SRE transcription. NIH 3T3 cells were trans- fected as described in Materials and Methods with 10 mg of cfos SRE CAT reporter gene and either 2.5 mg of CMV-4 vector (1CMV vector), 2.5 mg of CMV-C/EBPb(lz2) [1LAP(lz2)], 0.5 mg of CMV-LIP(p20) (1LIP), 2.5 mg of CMV-LAP (p35) (1LAP), or 2.5 mg each of CMV-C/EBPb(lz2) and CMV- LAP [1LAP, LAP(lz2)]. Total DNA in each transfection was adjusted to 15 mg with pUC19 DNA. Twenty-four hours after transfection, cells were serum de- prived for 36 h and all but the plates harvested at time zero were stimulated with 15% fetal calf serum as described in Materials and Methods. Cells were har- vested at the indicated times, and CAT activity was measured as described in Materials and Methods. Fold induction was calculated as the increase in CAT activity relative to that obtained with the reporter gene plus pUC19 DNA in serum-deprived cells at time 0. Values are the averages of three independent experiments, and error bars show standard deviations.

    Journal: Molecular and Cellular Biology

    Article Title: Regulation of the cfos serum response element by C/EBPbeta

    doi: 10.1128/mcb.17.3.1744

    Figure Lengend Snippet: FIG. 7. C/EBPb(lz2) inhibits SRE transcription. NIH 3T3 cells were trans- fected as described in Materials and Methods with 10 mg of cfos SRE CAT reporter gene and either 2.5 mg of CMV-4 vector (1CMV vector), 2.5 mg of CMV-C/EBPb(lz2) [1LAP(lz2)], 0.5 mg of CMV-LIP(p20) (1LIP), 2.5 mg of CMV-LAP (p35) (1LAP), or 2.5 mg each of CMV-C/EBPb(lz2) and CMV- LAP [1LAP, LAP(lz2)]. Total DNA in each transfection was adjusted to 15 mg with pUC19 DNA. Twenty-four hours after transfection, cells were serum de- prived for 36 h and all but the plates harvested at time zero were stimulated with 15% fetal calf serum as described in Materials and Methods. Cells were har- vested at the indicated times, and CAT activity was measured as described in Materials and Methods. Fold induction was calculated as the increase in CAT activity relative to that obtained with the reporter gene plus pUC19 DNA in serum-deprived cells at time 0. Values are the averages of three independent experiments, and error bars show standard deviations.

    Article Snippet: Approximately 8 mg of NIH 3T3 cell nuclear extract was mixed with 1 mg of BSA (lane 1), 1 ml of guinea pig preimmune serum (lane 2), 1 ml of guinea pig affinity-purified anti-LAP antibody (lane 3), or 1 ml of C/EBPb (lane 4), C/EBPa (lane 5), or E12 (lane 6) peptide antibodies from Santa Cruz Biotechnology in the presence of 20 ng of aprotinin at 48C for 2 h. Protein samples were then mixed with 1 ng of 32P-labeled SRE DNA in the presence of 2 mg of poly(dI-dC):poly(dI-dC) as described in Materials and Methods for buffer I conditions.

    Techniques: Plasmid Preparation, Transfection, Activity Assay

    FIG. 9. SRE BP binding to SRE mutant DNAs. Gel shift assays were per- formed as described in Materials and Methods using buffer I conditions with approximately 8 mg of nuclear extract from NIH 3T3 cells and 1 ng of 32P-labeled SRE DNA in the presence of 2 mg of poly(dI-dC):poly(dI-dC) and the indicated amount of competitor SRE mutant oligonucleotide (solid bars) or wild-type SRE DNA (open bars). Radioactivity levels in the SRE BP-DNA complexes on the dried gel were quantified with a Bio-Rad molecular imager. The ratio of DNA bound in the presence versus the absence of competitor DNA for each concen- tration of competitor DNA added to the binding reaction mixtures was calcu- lated and plotted as shown. Values are the averages of duplicate determinations. Sequence changes between the wild type and FSS (A), SRE.M (B), and SRE.LP (C) mutants are shown at the left. Complete sequences of the wild-type and mutant SRE oligonucleotides used in the competitions are given in Materials and Methods. (D) A representative electrophoretic mobility shift assay used to obtain the graphical data presented in panel B is shown. Only the SRF-DNA and SRE BP-DNA complexes are shown. The amount of SRE BP complex plotted in panels A to C represents the summation of the radioactivity levels in each of the three discernible bands within the SRE BP complex, although similar results were obtained by considering each of the three SRE BP bands individually. This figure was prepared with a Mirror 800 color scanner and a Power Macintosh 8100/80 with Adobe Photoshop 2.5.1 and Adobe Illustrator 5.5.

    Journal: Molecular and Cellular Biology

    Article Title: Regulation of the cfos serum response element by C/EBPbeta

    doi: 10.1128/mcb.17.3.1744

    Figure Lengend Snippet: FIG. 9. SRE BP binding to SRE mutant DNAs. Gel shift assays were per- formed as described in Materials and Methods using buffer I conditions with approximately 8 mg of nuclear extract from NIH 3T3 cells and 1 ng of 32P-labeled SRE DNA in the presence of 2 mg of poly(dI-dC):poly(dI-dC) and the indicated amount of competitor SRE mutant oligonucleotide (solid bars) or wild-type SRE DNA (open bars). Radioactivity levels in the SRE BP-DNA complexes on the dried gel were quantified with a Bio-Rad molecular imager. The ratio of DNA bound in the presence versus the absence of competitor DNA for each concen- tration of competitor DNA added to the binding reaction mixtures was calcu- lated and plotted as shown. Values are the averages of duplicate determinations. Sequence changes between the wild type and FSS (A), SRE.M (B), and SRE.LP (C) mutants are shown at the left. Complete sequences of the wild-type and mutant SRE oligonucleotides used in the competitions are given in Materials and Methods. (D) A representative electrophoretic mobility shift assay used to obtain the graphical data presented in panel B is shown. Only the SRF-DNA and SRE BP-DNA complexes are shown. The amount of SRE BP complex plotted in panels A to C represents the summation of the radioactivity levels in each of the three discernible bands within the SRE BP complex, although similar results were obtained by considering each of the three SRE BP bands individually. This figure was prepared with a Mirror 800 color scanner and a Power Macintosh 8100/80 with Adobe Photoshop 2.5.1 and Adobe Illustrator 5.5.

    Article Snippet: Approximately 8 mg of NIH 3T3 cell nuclear extract was mixed with 1 mg of BSA (lane 1), 1 ml of guinea pig preimmune serum (lane 2), 1 ml of guinea pig affinity-purified anti-LAP antibody (lane 3), or 1 ml of C/EBPb (lane 4), C/EBPa (lane 5), or E12 (lane 6) peptide antibodies from Santa Cruz Biotechnology in the presence of 20 ng of aprotinin at 48C for 2 h. Protein samples were then mixed with 1 ng of 32P-labeled SRE DNA in the presence of 2 mg of poly(dI-dC):poly(dI-dC) as described in Materials and Methods for buffer I conditions.

    Techniques: Binding Assay, Mutagenesis, Gel Shift, Labeling, Radioactivity, Sequencing, Electrophoretic Mobility Shift Assay